Fenofibrate Monotherapy Induced Rhabdomyolysis-Reference-Cited by-同舟云学术

Fenofibrate Monotherapy Induced Rhabdomyolysis

Published:2003-08-01 Issue:8 Volume:26 Page:2482-2483
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Barker Billie J.¹,Goodenough Roger R.²,Falko James M.¹

Affiliation:

1. Department of Internal Medicine, Riverside Methodist Hospital, Columbus, Ohio

2. Department of Family Medicine, Upper Valley Medical Center, Troy, Ohio

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/26/8/2482/661064/2482.pdf

Reference7 articles.

1. Jen SL, Chen JW, Lee WL, Wang SP: Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study. Chinese Medical Journal 59:217–224, 1997

2. Insua A, Massari F, Rodriguez Moncalvo JJ, Ruben Zanchetta J, Insua AM: Fenofibrate or gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study. Endocr Pract 8:96–101, 2002

3. Choice of lipid-regulating drugs. Med Letter 43:43–48, 2001

4. Despres J: Increasing high-density lipoprotein cholesterol: an update on fenofibrate. Am J Cardiol 88:30N–236N, 2001

5. Ellen RL, McPherson R: Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia. Am J Cardiol 81:60B–65B, 1998

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4;Journal of Pediatric Endocrinology and Metabolism;2022-04-13

2. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus;Medicine;2020-05-22

3. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism;Medicine;2018-04

4. Lipid lowering agents of natural origin: An account of some promising chemotypes;European Journal of Medicinal Chemistry;2017-11

5. Recent Research Progress in Natural Bioactive Constituents against Lipid Metabolic Diseases;Current Topics in Medicinal Chemistry;2016-07-01